MktsMarkets

NeoGenomics, Inc.
NASDAQ: NEOKey statistics
NEO News
Stories mentioning NEO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 105,808 | 106,827 | 107,351 | 104,072 | 94,789 | 94,743 | 92,944 | 92,008 |
| Gross Profit | 80,864 | 83,343 | 80,446 | 77,258 | 73,246 | 77,257 | 74,880 | 72,494 |
| Operating Expenses | ||||||||
| Research & Development | 9,534 | 9,179 | 8,694 | 9,023 | 10,181 | 7,969 | 7,684 | 7,886 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 99,105 | 96,757 | 107,460 | 124,886 | 101,071 | 95,658 | 96,077 | 94,435 |
| Operating Income (Loss) | (18,241) | (13,414) | (27,014) | (47,628) | (27,825) | (18,401) | (21,197) | (21,941) |
| Interest Income | 1,273 | 1,523 | 1,563 | 2,263 | 3,721 | 4,328 | 4,673 | 4,592 |
| Interest Expense | ||||||||
| Other Expense | (12.00) | 84.00 | (335.00) | 482.00 | 65.00 | (431.00) | 317.00 | (2.00) |
| Pretax Income | (17,578) | (12,406) | (26,389) | (45,816) | (25,657) | (16,128) | (17,849) | (19,017) |
| Tax Provision | (472.00) | (2,525) | 740.00 | (724.00) | 266.00 | (804.00) | (150.00) | (375.00) |
| Net Income (Loss) | (17,106) | (9,881) | (27,129) | (45,092) | (25,923) | (15,324) | (17,699) | (18,642) |
| Earnings Per Share (Basic) | (0.08) | (0.12) | ||||||
| Earnings Per Share (Diluted) | (0.08) | (0.12) | ||||||
| Weighted Average Shares Outstanding (Basic) | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 |
| Weighted Average Shares Outstanding (Diluted) | 129,166 | 128,101 | 128,415 | 127,949 | 127,376 | 126,658 | 126,953 | 126,405 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NEO
NeoGenomics, Inc. (NASDAQ: NEO) is a stock listed on the Nasdaq Stock Market under the ticker symbol NEO. It last traded at $17.33 (Oct 30, 2026, 1:24 PM ET), down 3.4% on the day. That gives NeoGenomics a market capitalisation of $2.3B.
Over the past 52 weeks NEO has traded between $7.07 and $20.15.
For the quarter ended Mar 31, 2026 it reported a net loss of $17.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$17.1M |
| Dec 31, 2025 | — | -$9.9M |
| Sep 30, 2025 | — | -$27.1M |
| Jun 30, 2025 | — | -$45.1M |
From NeoGenomics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…